Friday, 12th September
CD1-MR1 Workshop 2025
Days
Tuesday, 9th September
Wednesday, 10th September
Thursday, 11th September
Friday, 12th September
Search
Speakers
Registration Opens
8:00AM - 4:00PM
Friday, 12th September
Foyer Area
Breakfast & Networking
8:00AM - 9:00AM
Friday, 12th September
Foyer Area
Introduction to Special Lecture: Translational Immunology
9:00AM - 9:05AM
Friday, 12th September
Auditorium
Chair: Branch Moody
Special Lecture: Translational Immunology
9:05AM - 9:40AM
Friday, 12th September
Auditorium
Chair: Branch Moody
MR1T cells monitor metabolic changes in tumor cells
-
Gennaro De Libero
Therapy of Cancer and Other Diseases 1
9:40AM - 10:30AM
Friday, 12th September
Auditorium
Chairs: Paolo Dellabona & Andrew Chancellor
Sponsored by:
Arovella Therapeutics
Anti-tumor adjuvancy by human CD4
+
iNKT cells
-
Jenny Gumperz
Developing CAR-NKT cells to reprogram the Tumor Microenvironment in Prostate Cancer
-
Tonya Webb
Morning Coffee Break & Networking
10:30AM - 11:05AM
Friday, 12th September
Foyer Area
Therapy of Cancer and Other Diseases 1
11:05AM - 12:30PM
Friday, 12th September
Auditorium
Chairs: Paolo Dellabona & Andrew Chancellor
Sponsored by:
Arovella Therapeutics
Understanding unconventional T cell development to generate an ‘off the shelf’ immunotherapy to treat human diseases
-
Daniel Pellicci
MAIT cell activation inhibits tumor growth in the liver
-
Tim Greten
Cancer Immunotherapy with CAR-Redirected NKT Cells
-
Leonid Metelitsa
Design of cytokine engineered invariant Natural Killer T (iNKT) cells for adoptive immunotherapy of cancer
-
Gloria Delfanti
Lunch & Networking
12:30PM - 1:30PM
Friday, 12th September
Foyer Area
SAB Business/Japan Planning Meeting - by invitation only
12:30PM - 1:30PM
Friday, 12th September
Therapy of Cancer and Other Diseases 2
1:30PM - 2:35PM
Friday, 12th September
Auditorium
Chairs: Giulia Casorati & Masaki Terabe
Sponsored by:
Arovella Therapeutics
CD1a-Targeted PD-1 Agonists for Localized Immunosuppression in Atopic Dermatitis
-
Mariolina Salio
Nanobodies to Leverage the MR1–MAIT Axis for Immunotherapy
-
Hui-Fern Koay
Glioblastoma-enriched glycosphingolipids modulate the function of human iNKT cells
-
Masaki Terabe
A protein scaffold for the facile generation of ligand-specific MR1 binders
-
Jingjia Liu
Short Stretching Break
2:35PM - 2:45PM
Friday, 12th September
Therapy of Cancer and Other Diseases 2
2:45PM - 3:50PM
Friday, 12th September
Auditorium
Chairs: Giulia Casorati & Masaki Terabe
Sponsored by:
Arovella Therapeutics
Adoptive immunotherapy of metastatic colon cancer with tumor redirected iNKT cells
-
Paolo Dellabona
iNKT cells: versatile platforms for direct and recombinant antigen receptor-mediated cancer therapies alone and in rational immunotherapy combinations
-
Mark Exley
Development of CAR-iNKT cells for the treatment and haematological malignancies and solid tumours
-
Robson Dossa
Closing Remarks, Awards & Next Location
3:50PM - 4:15PM
Friday, 12th September
Auditorium
Closing Social Event and Snacks for all Attendees
4:15PM - 5:00PM
Friday, 12th September
← Thursday